% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/BayesPostPredContinuous.R
\name{BayesPostPredContinuous}
\alias{BayesPostPredContinuous}
\title{Calculate Bayesian Posterior Probability or Bayesian Posterior Predictive Probability
for a Clinical Trial When Outcome is Continuous}
\usage{
BayesPostPredContinuous(
  prob = "posterior",
  design = "controlled",
  prior = "vague",
  CalcMethod = "NI",
  theta0,
  nMC = NULL,
  nINLAsample = NULL,
  n1,
  n2,
  m1,
  m2,
  kappa01,
  kappa02,
  nu01,
  nu02,
  mu01,
  mu02,
  sigma01,
  sigma02,
  bar.y1,
  bar.y2,
  s1,
  s2,
  r = NULL,
  ne1 = NULL,
  ne2 = NULL,
  alpha01 = NULL,
  alpha02 = NULL
)
}
\arguments{
\item{prob}{A character string specifying the type of probability to calculate
(\code{prob = 'posterior'} or \code{prob = 'predictive'}).}

\item{design}{A character string specifying the type of trial design
(\code{design = 'controlled'}, \code{design = 'uncontrolled'}, or \code{design = 'external'}).}

\item{prior}{A character string specifying the prior distribution
(\code{prior = 'N-Inv-Chisq'} or \code{prior = 'vague'}).}

\item{CalcMethod}{A character string specifying the calculation method
(\code{CalcMethod = 'NI'} for numerical integration, \code{CalcMethod = 'MC'} for Monte Carlo method,
\code{CalcMethod = 'WS'} for Welch-Satterthwaite approximation, or \code{CalcMethod = 'INLA'} for INLA).}

\item{theta0}{A numeric value representing the pre-specified threshold value.}

\item{nMC}{A positive integer representing the number of iterations for Monte Carlo simulation
(required only if \code{CalcMethod = 'MC'}).}

\item{nINLAsample}{A positive integer representing the number of iterations for INLA sampling
(required only if \code{CalcMethod = 'INLA'}).}

\item{n1}{A positive integer representing the number of patients in group 1 for a proof-of-concept (PoC) trial.}

\item{n2}{A positive integer representing the number of patients in group 2 for the PoC trial.}

\item{m1}{A positive integer representing the number of patients in group 1 for the future trial data.}

\item{m2}{A positive integer representing the number of patients in group 2 for the future trial data.}

\item{kappa01}{A positive numeric value representing the prior precision parameter related to the mean
for conjugate prior of Normal-Inverse-Chi-squared in group 1.}

\item{kappa02}{A positive numeric value representing the prior precision parameter related to the mean
for conjugate prior of Normal-Inverse-Chi-squared in group 2.}

\item{nu01}{A positive numeric value representing the prior degrees of freedom related to the variance
for conjugate prior of Normal-Inverse-Chi-squared in group 1.}

\item{nu02}{A positive numeric value representing the prior degrees of freedom related to the variance
for conjugate prior of Normal-Inverse-Chi-squared in group 2.}

\item{mu01}{A numeric value representing the prior mean value of outcomes in group 1 for the PoC trial.}

\item{mu02}{A numeric value representing the prior mean value of outcomes in group 2 for the PoC trial.}

\item{sigma01}{A positive numeric value representing the prior standard deviation of outcomes in group 1 for the PoC trial.}

\item{sigma02}{A positive numeric value representing the prior standard deviation of outcomes in group 2 for the PoC trial.}

\item{bar.y1}{A numeric value representing the sample mean of group 1.}

\item{bar.y2}{A numeric value representing the sample mean of group 2.}

\item{s1}{A positive numeric value representing the sample standard deviation of group 1.}

\item{s2}{A positive numeric value representing the sample standard deviation of group 2.}

\item{r}{A positive numeric value representing the parameter value associated with the distribution
of mean for group 2 when \code{design = 'uncontrolled'}.}

\item{ne1}{A positive integer representing the sample size for group 1 in external trial (can be NULL if no external treatment data).}

\item{ne2}{A positive integer representing the sample size for group 2 in external trial (can be NULL if no external control data).}

\item{alpha01}{A positive numeric value representing the scale parameter of the power prior for group 1 (can be NULL if no external treatment data).}

\item{alpha02}{A positive numeric value representing the scale parameter of the power prior for group 2 (can be NULL if no external control data).}
}
\value{
A numeric vector representing the Bayesian posterior probability or Bayesian posterior
predictive probability. The function can handle vectorized inputs.
}
\description{
This function computes Bayesian posterior probability or posterior predictive probability
for continuous outcome clinical trials. The function supports controlled, uncontrolled, and
external control designs with Normal-Inverse-Chi-squared or vague priors, using four calculation
methods: numerical integration, Monte Carlo simulation, Welch-Satterthwaite approximation, and INLA.
}
\details{
The function can obtain:
\itemize{
\item Bayesian posterior probability
\item Bayesian posterior predictive probability
}

Prior distribution of mean and variance of outcomes for each treatment group (k=1,2) can be either
(1) Normal-Inverse-Chi-squared or (2) Vague. The posterior distribution or posterior predictive
distribution of outcome for each treatment group follows a t-distribution.

Four calculation methods are available:
\itemize{
\item NI: Numerical integration method for exact computation
\item MC: Monte Carlo simulation for flexible approximation
\item WS: Welch-Satterthwaite approximation for computational efficiency
\item INLA: Integrated Nested Laplace Approximation for external data incorporation
}
}
\examples{
# Example 1: Numerical Integration (NI) method with N-Inv-Chisq prior
BayesPostPredContinuous(
  prob = 'posterior', design = 'controlled', prior = 'N-Inv-Chisq', CalcMethod = 'NI',
  theta0 = 2, n1 = 12, n2 = 12, kappa01 = 5, kappa02 = 5, nu01 = 5, nu02 = 5,
  mu01 = 5, mu02 = 5, sigma01 = sqrt(5), sigma02 = sqrt(5),
  bar.y1 = 2, bar.y2 = 0, s1 = 1, s2 = 1
)

# Example 2: Monte Carlo (MC) method with vague prior
BayesPostPredContinuous(
  prob = 'posterior', design = 'controlled', prior = 'vague', CalcMethod = 'MC',
  theta0 = 1, nMC = 10000, n1 = 12, n2 = 12,
  bar.y1 = 3, bar.y2 = 1, s1 = 1.5, s2 = 1.2
)

# Example 3: Welch-Satterthwaite (WS) approximation with N-Inv-Chisq prior
BayesPostPredContinuous(
  prob = 'predictive', design = 'controlled', prior = 'N-Inv-Chisq', CalcMethod = 'WS',
  theta0 = 0.5, n1 = 15, n2 = 15, m1 = 100, m2 = 100,
  kappa01 = 3, kappa02 = 3, nu01 = 4, nu02 = 4, mu01 = 2, mu02 = 2,
  sigma01 = 2, sigma02 = 2, bar.y1 = 2.5, bar.y2 = 1.8, s1 = 1.8, s2 = 1.6
)

\dontrun{
# Example 4: INLA method with external control data (requires INLA package)
BayesPostPredContinuous(
  prob = 'posterior', design = 'external', prior = 'vague', CalcMethod = 'INLA',
  theta0 = 1.5, nINLAsample = 5000, n1 = 12, n2 = 12,
  bar.y1 = 4, bar.y2 = 2, s1 = 1.2, s2 = 1.1,
  ne2 = 20, alpha02 = 0.5
)
}

}
